VMC
41
2
LNC
28
3
AZO
46
3
AAP
26
5
JNJ
30
4
MTB
38
4
PFG
27
7
KMI
69
8
WAT
55
11
DD
44
2
MRK
25
2
AEE
51
3
MAS
46
3
LOW
42
14
OMC
37
2
LEG
16
2
IPG
43
3
SCHW
40
3
USB
50
3
TRV
34
4
VMC
41
2
LNC
28
3
AZO
46
3
AAP
26
5
JNJ
30
4
MTB
38
4
PFG
27
7
KMI
69
8
WAT
55
11
DD
44
2
MRK
25
2
AEE
51
3
MAS
46
3
LOW
42
14
OMC
37
2
LEG
16
2
IPG
43
3
SCHW
40
3
USB
50
3
TRV
34
4
Financhill
Back

Blueprint Medicines Stock Predictions

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
40

BPMC
Blueprint Medicines

Last Price:
$89.16
Seasonality Move:
2.18%

7 Day Trial

ALL ACCESS PASS

$ 7

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 30.8% based on the past 9 years of stock performance.
  • Blueprint Medicines has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 30.8% based on the past 9 years of stock performance.

Blueprint Medicines Stock Rating

Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
121.90
52-Week Low:
72.24

Prediction Charts

Market Cap:
5.7B
Price in USD:
90.19
Volume:
1.2M
Beta:
0.88

Technical Analysis

SMA50:
92.37
SMA100:
92.00
SMA200:
96.72
52-Wk Change:
7.22%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 90.19 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 96.38 96.53 96.91 95.79
Dec-4 96.04 96.52 98.49 95.80
Dec-5 95.84 95.08 96.53 93.91
Dec-6 95.60 95.97 97.04 94.33
Dec-9 96.29 94.57 97.00 94.44
Dec-10 95.23 95.39 97.44 94.47
Dec-11 95.32 94.47 97.00 93.41
Dec-12 94.13 92.58 94.91 92.17
Dec-13 92.72 93.19 93.77 92.00
Dec-16 93.17 95.39 96.09 91.88
Dec-17 94.59 96.48 96.98 94.55
Dec-18 97.05 91.78 98.41 91.16
Dec-19 91.84 88.93 92.29 86.02
Dec-20 88.12 90.19 90.99 87.99

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.